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1. Executive Summary 
 
One method of treating cancer, hyperthermia therapy, involves increasing the temperature of 
tumors above a critical threshold to induce cell death. The specific treatment we are studying 
involves using magnetic nanoparticles to induce hyperthermia. The nanoparticles are injected 
directly into the tumor, and the application of a rapidly fluctuating magnetic field heats the 
nanoparticles. Using this method, only tissues at and immediately adjacent to the injection sites 
are heated. While the mechanism of hyperthermia therapy has been well characterized, 
optimizing the therapy is still an area of active research. Many factors such as injection site 
locations and duration of magnetic field application need to be precisely controlled to maximize 
damage to cancerous tissue while minimizing damage to benign tissue. 
 
In this project, we modeled the treatment in COMSOL to address these optimization problems. 
In both the 2D and 3D models, diffusive heat transfer with transient analysis was simulated by 
COMSOL. For our model, we drafted an irregularly shaped tumor in 2D and an arbitrarily 
shaped 3D tumor. To model the heating of the tissue, we incorporated specific absorption rate 
(SAR) approximation to model the collective heating of nanoparticles at the injection sites. The 
heating of the tumor was implemented via a heat generation term that was dependent on the 
nanoparticle distribution. We determined that the tumor should be heated above 43 °C but less 
than 100 °C, and the surrounding healthy tissue should be maintained below 43 °C to prevent 
unnecessary cell death. Therefore, we defined optimization of the therapy to mean maximization 
of tumor destruction and minimization of normal tissue damage. We subsequently optimized the 
solution for heating duration and injection site distribution by minimizing an objective function. 
Sensitivity analysis was performed on key parameters such as injection location, A, and ro in 
order to determine their influence on optimal heating time. We validated the implementation of 
SAR physics in COMSOL by comparing it to an analytical solution for heating at a point source. 
Validation of the SAR model against the actual physics of nanoparticle injection is an emerging 
area of research and beyond the scope of this study. 
Our results show that multiple injection sites allow for a more controlled destruction of tissue. 
The injection site locations were optimized such that the amount of tumor tissue destroyed was 
maximized and healthy tissue damaged minimized. Single injection sites are limited to a 
spherical distribution of nanoparticles and therefore a spherical area of tissue ablation. We also 
determined that increasing values of A and decreasing ro, which relates to increased injection 
concentrations, greatly reduces the time of heating required to bring the tumor tissue to the 
desired temperature. The location of the injection site was the most important factor to consider 
in optimization.  
The significance of this research is that magnetic nanoparticle hyperthermia treatment can 
benefit from this precise engineering transport model to achieve greater effect. More specifically, 
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in clinical settings, this model may aid physicians in determining optimal injection sites and 
treatment length, and improve the overall prognosis for patients. 
 
2. Introduction 
 
Cancer is a disease characterized by uncontrolled and unregulated cell growth. The growing cells 
form malignant tumors and spread to nearby and/or distant healthy tissue sites. When left 
untreated, cancer will cause the eventual death of the patient. Cancer is currently the second most 
common cause of death in the U.S. The American Cancer society estimates that about 1,638,910 
new cancer cases are expected to be diagnosed in 2012, and about 577,190 Americans are 
expected to die of cancer [1]. Presently, there are a number of ways to treat malignant cancer: 
surgical removal of bulk tumor, chemotherapy, and radiation therapy are currently highly utilized 
therapies [1]. Most regimens utilize a combination of aggressive targeting of the bulk tumor and 
prevention of the spread of metastasizing tumor. However, most of these cancer therapies are 
either highly invasive or result in undesirable side effects. Hyperthermia therapy has recently 
gained some attention as a viable cancer treatment due to its relatively low risk, low cost, ease of 
implementation, and minimal side effects. Therefore, hyperthermia therapy garners further 
research into its potential in becoming a cancer treatment of choice. 
 
Previous studies have shown that localized hyperthermia therapy using magnetic nanoparticles 
was successful in killing tumors in clinical and preclinical tests [2]. The nanoparticles that were 
used in their study, iron oxides magnetite (Fe3O4) and maghemite γ-Fe2O3, are shown to be 
biocompatible in human tissue [7]. The experiment involved injecting the nanoparticles into the 
surrounding tumor extracellular space at single and multi-injection sites. A magnetic field was 
then applied to excite the nanoparticles to stimulate localized hyperthermia within the tumor [3]. 
The application of a rapidly fluctuating magnetic field heats the nanoparticles, effectively 
heating the tumor in localized regions while minimizing over-heating of surrounding healthy 
tissue. Studies have also reported that the duration of heating, also known as thermal dose, and 
the distribution of the nanoparticles both have tremendous influences on the effectiveness of the 
treatment [4,5]. 
 
The aim of this project was to optimize the distribution of nanoparticles and the thermal dose to 
effectively kill the bulk tumor while concomitantly minimizing damage to the surrounding 
healthy tissue. We will model the magnetic nanoparticle heating of 2D and 3D tumor geometries 
and determine the effect of various parameters on the efficacy of the treatment. Our goal is to be 
able to identify the parameters that play the greatest role in optimization and how one might 
systematically be able to determine the best possible combination of those parameters to 
minimize healthy tissue loss and offer the best outcome for the patient. Consistent with our aim, 
our design objectives are: 
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3. Design Objectives 
• Reach a specific threshold temperature (> 43 °C) inside the tumor to kill tumor cells  
• Minimize damage to surrounding healthy cells (< 43 °C) 
• Minimize excessive heating to all cells (< 100 °C) 
• Determine the parameters needed to optimize the treatment such as: 
• Injection site locations 
• Thermal dose 
• Maximum specific absorption rate 
• Nanoparticle distribution distance from center of injection 
 
3.1 Schematic 
2D Geometry: 3D Geometry: 
 
 
 Governing Equation: 
𝜋 �
𝜕2𝑇
𝜕𝑥2
+ 𝜕2𝑇
𝜕𝑦2
�  + �𝑄𝑖𝑛
𝑖=1
= 𝜕𝑇
𝜕𝑡
 𝜋 �
𝜕2𝑇
𝜕𝑥2
+ 𝜕2𝑇
𝜕𝑦2
+ 𝜕2𝑇
𝜕𝑧2
�  + �𝑄𝑖𝑛
𝑖=1
= 𝜕𝑇
𝜕𝑡
 
𝜋 = �(x − xi)2 + (y − yi)2 𝜋 = �(x − xi)2 + (y − yi)2 + (𝑧 − 𝑧𝑖)2 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝐴𝑏𝑠𝑜𝑝𝜋𝑡𝑖𝑜𝑛 𝑅𝑎𝑡𝑒 = 𝑄𝑖 = 𝐴𝑒− 𝑟2𝑟02 
Boundary Condition: Flux = 0 at all edges of normal tissue 
Initial Condition: T0 = 37 °C everywhere 
Figure 1: Schematic of the 2D and 3D geometries used to simulate tumor tissue. The x, y, and z 
axis of each model is in units of meters. The governing equations used are the 2D and 3D heat 
transfer equations with the conduction, transient, and heat generation terms. 
Normal tissue 
Tumor tissue 
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In both the 2D and 3D models, the geometry of the tumor was set arbitrarily to demonstrate each 
model’s ability to predict the temperature profile for any tumor geometry. The size of the 
simulated tumor tissues are on the length scale of realistic cancer tumors (approximately 2 cm). 
The governing equation used in each model is the heat transfer equation which includes the 
conductive, generation, and transient terms. Each injection site acts as a source of the heat 
generation term, which is given by the specific absorption rate (SAR) (Appendix A). The 
particles were assumed to be static once injected into the tumor cells so that mass transfer could 
be neglected in this model. 
Injecting magnetic nanoparticles at a single injection site gives little control of the temperature 
distribution within an irregularly shaped tumor (Figure 2A). In contrast, if there are multiple 
injection sites, volumetric heating at a point is the sum of the heating term from each injection 
site (Figure 2B). This effect allows for precise shaping of the temperature distribution within the 
tissue to destroy a tumor of irregular geometry while leaving the surrounding normal tissue 
undamaged. 
Figure 2: Schematic showing tumor geometry and location of (a) single injection site and (b) 
multiple injection sites. At a point (x, y) the volumetric heating term, Q, is a sum of the 
exponential distributions from each injection site I1, I2, I3. 
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4. Results/Discussion 
4.1 Solution Optimization 
We determined the optimal location for the injection sites by minimizing an objective function 
(J). This function was set such that elements inside the tumor which are below 43 °C increase the 
value of the function and elements outside the tumor which are above 43 °C also increase the 
value of the function, but to a lesser extent (see below). 
 
𝐽 =  �𝐹𝑇𝑢𝑚𝑜𝑟(𝑇𝑖) + �𝐹𝐻𝑒𝑎𝑙𝑡ℎ𝑦�𝑇𝑗� 
𝑗
 
𝑖
 
𝐹𝑇𝑢𝑚𝑜𝑟(𝑇) = � 10, 𝑇 < 430, 43 ≤ 𝑇 < 10010000, 𝑇 ≥ 100  
𝐹𝐻𝑒𝑎𝑙𝑡ℎ𝑦(𝑇) = � 0, 𝑇 < 431, 43 ≤ 𝑇 < 10010000, 𝑇 ≥ 100  
Here we place a greater importance on destroying the tumor tissue over protecting the 
surrounding normal tissue by weighting a given volume of tumor tissue below 43 °C ten times 
more than the same volume of normal tissue above 43 °C. Above 100 °C the tissue will begin to 
boil causing catastrophic injury to the patient, so any volume above 100 °C was given an 
extremely high weight of 10000. 
A 2D transient solution was performed in COMSOL as a preliminary study to determine how 
long the magnetic field should be continuously applied to induce the desired temperature of 
43 °C throughout the entire tumor interior.  
 
Optimized 2D solution 
 
Three injection sites were arbitrarily placed in the 2D tumor geometry evenly spaced from the 
boundaries. The location of each injection site was then adjusted in 2 mm increments and the 
solution for every combination of injection site locations was found.  The optimal injection site 
locations were found using the objective function discussed previously (Figure 3). 
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Figure 3: Surface plot of the 2D tumor geometry with optimized injection site locations. The 
ideal heating time (87 s) corresponds to the maximum amount of tumor destroyed and minimal 
damage to healthy tissue.  
 
For the optimized 2D solution, 0.156 % of the original tumor area was not heated above the 
therapeutic temperature and thus survived. In contrast, the amount of healthy tissue killed was 
equivalent in size to 16 % of the original tumor area.  
 
It would seem that the 2D solution provides a good estimate for optimal injection location and 
treatment time. However, a 3D representation would better capture the geometry of an actual 
tumor and thus would provide a more accurate result. 
 
Optimized 3D 
A single injection site location was initially chosen in our 3D model. After heating for two and a 
half hours, the entire tumor was not yet heated to the target therapeutic temperature of 43 °C, 
which indicated that tumor injection site optimization was important to improve therapeutic 
efficiency. Furthermore, the result indicated that optimization of the solution required multiple 
injection sites. 
 
The locations of 4 injection sites within the tumor were optimized using the objective function. 
This was achieved through fixing 1 injection site to the tumor’s center of mass and setting the 
other 3 injection sites somewhere along the major axis of each ellipsoid arm. 
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Figure 4: Contour plots of the A) fine optimized solution, B), C), D) coarse optimized solutions 
for different objective function values. The target temperature of 43 °C is just barely achieved at 
the outermost points of each tumor arm. 
A coarse optimization was first performed for the location of the 3 injection sites in each of the 
ellipsoid tumor arms. The injection sites were determined by moving out from the center of each 
ellipsoid along the respective major axis in 2 mm increments. The objective function was then 
evaluated at each of the 27 possible injection site combinations. The optimal injection site 
locations were determined to be the coarse optimization with the minimum objective function 
value of 1.22E-06. We subsequently performed a fine optimization around the solution for the 
coarse optimization to refine the location of the optimal injection sites. This was done by 
considering 3 additional injection sites in each tumor arm: one at the previous optimal location, 
one 1 mm closer to the tumor center along the ellipsoid axis, and one 1 mm farther away. The 
new optimal locations for the injection sites were found with a new minimum value of the 
objective function of 1.15E-06 (Figure 5).  After heating for 306 seconds, the refined optimal 
location has only 0.45 % of the tumor volume below 43 °C and 35 % of the tumor volume of the 
normal tissue above 43 °C (Figure 4). This was compared to the heating for 297 seconds, which 
yielded in 0.87 % of the tumor volume below 43 °C and 33 % of the tumor volume of the normal 
tissue above 43 °C for the original coarse solution. 
 
A) J = 1.15E-6 B) J = 1.22E-6 
C) J = 2.96E-6 D) J = 4.05E-6 
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Figure 5: Plot of normalized objective function for the optimized solution. The objective 
function is minimized at 306 seconds. 
 
4.2 Sensitivity Analysis 
The sensitivity of the optimal heating time to A and ro was computed for the 3D tumor geometry 
with optimal injection site locations (J = 1.15E-6). For both A and ro a parametric sweep of 10 
values ranging from half to double of the original literature values was performed and the 
corresponding optimal heating time was recorded for each value (Figure 6). 
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Figure 6: Sensitivity of optimal heating time to parameters A (blue) and ro  (red). The optimal 
heating time is extremely sensitive to changes in ro (e.g. 13 % decrease in ro increases the optimal 
heating time by about 120%). 
These results indicate that the model is highly sensitive to the SAR parameters as a 16 % 
increase in ro results in over a 100 % increase in the heating time required to achieve a similar 
level of hyperthermia treatment. Since this parameter is related to the injection rate and 
concentration of nanoparticles, great care must be taken when injecting the nanoparticles since 
even a slight amount of variability can have a large impact on the optimal therapy duration. 
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4.3 Validation 
To validate that COMSOL was correctly implementing the specific absorption rate heating 
model in the vicinity of each injection site, we compared the COMSOL solution to a similar 
analytical solution at steady state. In COMSOL, a single injection site was placed in the center of 
a large domain with constant temperature (37 °C) boundary conditions. The problem was then 
solved at steady state. This COMSOL solution for heating from an injection site was compared 
to the known steady state analytical solution for a point emitting a constant heat flux:  
𝑇 = 𝑄𝑡𝑜𝑡4𝜋𝜋𝜋 +  𝑇∞ 
 
Where T is the temperature, 𝑄𝑡𝑜𝑡 is the total power output, k is the thermal conductivity, r is the 
distance away from the point source, and 𝑇∞ is the temperature far away from the heat source. 
In order for the two solutions to be directly comparable, the total power output of the point 
source was set equal to the total power output of one injection site. The total power output of a 
single injection site was calculated by calculating the triple integral of the volumetric heating Q 
with respect to each of the 3 spatial coordinate direction with integration bounds equal to the 
domain size (numerical integration using the triplequad() function built into MATLAB). Using 
this method the total power was found to be 0.317 W. This result was verified in COMSOL by 
placing a single injection site in a domain with 0 flux at the boundaries. With a 0 flux boundary 
condition the total energy input into the system by the injection site heating is equal to the 
thermal energy stored by the system. Knowing the heating time of the COMSOL solution, the 
power output of a single injection site was found to vary less than 2 % from the integral solution 
verifying that this is the correct answer. 
A plot of steady state temperature vs. distance from the inject site/point source was produced for 
both the COMSOL solution for a single injection site and the analytical solution for a point 
source with identical total power output to one injection site (Figure 7). The solutions are in 
close agreement having similar distributions. Some variation in the solutions is expected because 
in the injection site case the heating is spread over a larger area than for the point source. Indeed, 
the temperature near the heating source is slightly greater for the point source because of the 
greater concentration of heating. Overall, the two solutions are sufficiently similar to validate 
COMSOL’s implementation of the Specific Absorption Rate Model physics. 
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Figure 7: Validation of the specific absorption rate heating model physics implementation in 
COMSOL. The steady state solution for a single injection site (red) in COMSOL is in close 
agreement with the analytical solution for heating from a point source (blue) of equal total power 
out. 
Validation of the Specific Absorption Rate Model to the actual physics of nanoparticle injection 
and particle distribution is still an emerging area of research in the literature and beyond the 
scope of this study [3,4,5,7]. 
5. Conclusion and Design Recommendations 
 
From the results, we see that our model can indeed be used to predict the optimal spatial 
distribution of injection sites for nanoparticle hyperthermia cancer treatment. Optimizing 
injection site locations greatly increased the precision of the heating, effectively targeting tumor 
tissue while minimizing damage to surrounding healthy tissue. The comparison of the SAR 
model with the analytical solution for heating from a point source has shown that the model 
produces valid physical results, and thus we can expect the modeling of our tumor hyperthermia 
to be equally valid. 
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In order to increase the relevance and utility of our model, several issues must be addressed. 
First, although the SAR model has been shown to be valid, future experimentation is necessary 
to correlate A and ro to physical parameters such as injection rate, injection volume, injection 
density, and magnetic field strength/frequency. This is especially important for ro since it was 
our most sensitive parameter. Second, we could improve upon the SAR model by modeling the 
actual diffusion of the nanoparticles followed by magnetic heating. This could broaden the 
possible applications of this model, allowing for modeling of processes such as drug delivery via 
nanoparticles. Modeling nanoparticle diffusion would require us to account for other phenomena 
such as deposition effects and electrostatic interaction between particles and tissue. 
 
Our model has several realistic constraints as well. In terms of health safety, our model could be 
improved. For example, we placed a relative importance of killing tumor tissue to keeping 
healthy tissue undamaged at a 10:1 ratio in our objective function. In reality, this ratio should be 
much higher, since leaving detectable amounts of tumor tissue undestroyed would undermine the 
treatment altogether and render it ineffective. Also, we considered cell death to occur when 
tissue temperatures reached 43 °C. It would be more accurate to require the tissue to be 
maintained at a given temperature for a certain amount of time before considering it to be 
completely killed. These more rigorous requirements would undoubtedly result in greater healthy 
tissue damage and less picturesque final solutions, but would likely improve the prognoses of the 
cancer treatments in the long run. 
 
Economic constraints are another barrier in this design. First, we need to consider the cost of 
further research to characterize nanoparticle distribution as a function of the aforementioned 
physical parameters. Second, in order for this treatment to work properly, an accurate three 
dimensional image of the tumor with high spatial resolution is needed. This can be obtained 
using a high resolution MRI machine, but will incur high costs. Similarly, high resolution 
imaging is needed not only for obtaining accurate tumor geometry, but also in the actual surgical 
procedure. In order to inject nanoparticles at specific locations on the order of millimeters, real 
time imaging with high resolution would be needed to guide the surgical device to the correct 
location. Further costs would arise from the fact that the surgery would need to be performed by 
a highly trained surgeon. 
 
Despite these constraints, nanoparticle hyperthermic treatment is a developing technology that 
has the potential to improve the current methodology of treating cancer and improve the 
prognoses of individuals with cancer. Further research is required to more accurately model the 
actual physical processes involved before it is ready for clinical use. 
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Appendix A 
 
Governing Equations: 
2-D Heat transfer equation with volumetric heat generation from multiple injection sites: 
𝜋 �
𝜕2𝑇
𝜕𝑥2
+ 𝜕2𝑇
𝜕𝑦2
� + �𝑄𝑖𝑛
𝑖=1
= 𝜕𝑇
𝜕𝑡
 
3-D form of previous equation: 
𝜋 �
𝜕2𝑇
𝜕𝑥2
+ 𝜕2𝑇
𝜕𝑦2
+ 𝜕2𝑇
𝜕𝑧2
�  + �𝑄𝑖𝑛
𝑖=1
= 𝜕𝑇
𝜕𝑡
 
Where 𝑄𝑖 = 𝐴𝑖𝑒−𝑟2/𝑟02 and is the volumetric heating source at a point from a single injection site. 
This heat generation term is known as the specific absorption rate (SAR) and has been shown in 
literature to model the hyperthermia process [2,3,4]. Here A is the maximum value of the specific 
absorption rate at the center of injection and 𝜋𝑜 is the dimensional radius that is associated with 
how far from the injection site heating affects the tissue.  We obtained both of these parameters 
from literature [2,3]. For the 2D model, r is the distance from the center of an injection site at 
(𝑥𝑖, 𝑦𝑖) to any location (x, y) in the domain: 
𝜋 = �(𝑥 − 𝑥𝑖)2 + (𝑦 − 𝑦𝑖)2 
 
In the 3D model, r is similar but also accounts for the z axis: 
 
𝜋 = �(x − xi)2 + (y − yi)2 + (𝑧 − 𝑧𝑖)2 
 
Boundary Conditions: Flux = 0 around all edges of the domain 
Initial Conditions: T = 37 °C everywhere 
 
The boundary and initial conditions are the same in the 2D and 3D models. A flux of 0 around 
the normal tissue perimeter was chosen as the boundary condition because it was assumed that 
the tumor was much smaller in size compared to the surrounding tissue and thus very little heat 
would diffuse to the outer boundary. This assumption was valid through the relatively short time 
interval that was simulated in COMSOL. An initial temperature of 37 °C was used to replicate 
regular internal body temperature. 
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Table 1: Input parameters for the specific absorption rate heating model and tumor tissue. All 
parameters were obtained from Salloum et al [2]. 
 
A (W/m3) 1.91E6 
ro (m) 3.1E-3 
k (W/m∙K) 0.5 (normal) 0.55 (tumor) 
cp (J/kg∙K) 4200 
ρ (kg/m3) 1000 
 
Appendix B 
 
The 2D transient heat transfer by conduction model was solved using a direct UMFPACK linear 
system solver. The time step was fixed at a 1 second interval and the model was simulated for 
120 seconds. Calculations were performed using a relative tolerance of 0.01 and absolute 
tolerance of 0.001. 
 
In the 3D model, the transient heat transfer by conduction equation was solved in COMSOL 
using the conjugate gradients linear system solver. Time stepping was set at a 1 second interval 
for a total simulation of 600 seconds. Values for relative tolerance and absolute tolerance were 
set to 0.01 and 0.001 respectively. 
 
2D and 3D Mesh 
We created our mesh using the free mesh parameter method. We anticipated the temperature to 
vary greatly near the nanoparticle injection sites, so we specified COMSOL to have a smaller 
mesh element size immediately around the injection sites. Similarly, we specified a smaller mesh 
size around the tumor-normal tissue border because we wanted to make the temperature profile 
at this border as precise as possible. In 2D, our entire mesh consisted of 19249 elements, as 
shown by Figure 8. 
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Figure 8: Mesh (grey lines) for the 2D tumor geometry. The black line indicates the border 
between tumor (inside) and normal (outside) tissue.  
 
Figure 9: 3D tumor geometry mesh with 10861 elements. Free mesh with coarse predefined 
element sizes was utilized in this diagram. 
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The 3D geometry (Figure 9) was created in COMSOL out of 3 ellipsoids and 1 sphere to imitate 
tumor geometries in vivo [2,3]. Injection sites were initially chosen to be at the center of each 
ellipsoid and the center of the sphere. 
We performed mesh convergence on the 3D geometry using the default free mesh. The 
temperature was evaluated at the tumor center and outer most points on each tumor arm. 
Convergence occurred by 38000 elements so this mesh was used for the remainder of the 
analysis. Computation time was on the scale of tens of seconds. 
 
Mesh Convergence Analysis 
Figure 10 shows that using a finer mesh near the boundaries and injection sites is not necessary 
since both types of meshes provide similar results. Since the computation time does not increase 
much even with a higher number of elements, the finer mesh was still used since it produced 
plots with better resolution. 
 
 
Figure 10: Mesh convergence plot of the average tumor temperature. Average temperature does 
not change much after 295 mesh elements. 
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Figure 11: 3D Mesh convergence plot. Temperature at the end of each of tumor arm does not 
change with increasing element size. 
Temperature convergence was tested at different points instead of taking the average temperature 
of the whole tumor in the 3D model due to a greater degree of temperature variation that 
occurred within the 3D tumor (Figure 11). Convergence occurs even at a low number of mesh 
elements. 
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